Summary
WiseGuyReports.com adds “Radiopharmaceutical Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.
This report provides in depth study of “Radiopharmaceutical Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radiopharmaceutical Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
This report studies the global Radiopharmaceutical market status and forecast, categorizes the global Radiopharmaceutical market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.
The global Radiopharmaceutical market is valued at 4940 million US$ in 2017 and will reach 9520 million US$ by the end of 2025, growing at a CAGR of 8.6% during 2018-2025.
The major manufacturers covered in this report
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Oncology
Cardiology
Other
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3213650-global-radiopharmaceutical-market-research-report-2018
Major Key Points in Table of Content
Global Radiopharmaceutical Market Research Report 2018
1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Radiopharmaceutical Segment by Type (Product Category)
1.2.1 Global Radiopharmaceutical Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Radiopharmaceutical Production Market Share by Type (Product Category) in 2017
1.2.3 Actinium-225
1.2.4 Lutetium-177
1.2.5 Radium-223
1.2.6 Holmium-166
1.2.7 Other
1.3 Global Radiopharmaceutical Segment by Application
1.3.1 Radiopharmaceutical Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market by Region (2013-2025)
1.4.1 Global Radiopharmaceutical Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Radiopharmaceutical (2013-2025)
1.5.1 Global Radiopharmaceutical Revenue Status and Outlook (2013-2025)
1.5.2 Global Radiopharmaceutical Capacity, Production Status and Outlook (2013-2025)
……
7 Global Radiopharmaceutical Manufacturers Profiles/Analysis
7.1 Bracco Imaging
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Radiopharmaceutical Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bracco Imaging Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Radiopharmaceutical Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Mallinckrodt
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Radiopharmaceutical Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Mallinckrodt Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Nordion
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Radiopharmaceutical Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Nordion Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Triad Isotopes
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Radiopharmaceutical Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Triad Isotopes Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Lantheus
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Radiopharmaceutical Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Lantheus Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 IBA Group
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Radiopharmaceutical Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 IBA Group Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 GE Healthcare
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Radiopharmaceutical Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GE Healthcare Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 China Isotope & Radiation
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Radiopharmaceutical Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 China Isotope & Radiation Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Jubilant Pharma
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Radiopharmaceutical Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Jubilant Pharma Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Eli Lilly
7.12 Advanced Accelerator Applications
7.13 SIEMENS
7.14 Dongcheng
7.15 Navidea
At any Query @ https://www.wiseguyreports.com/enquiry/3213650-global-radiopharmaceutical-market-research-report-2018
Continued….
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com